BioNTech SE (BNTX.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec4

Jefferies Maintains 'Buy' Rating on BioNTech with a Target of $151

21:23

Nov26

BioNTech SE announces acquisition of CureVac's certain rights

12:30

Nov17

FactSet Downgrades BioNTech SE - ADR's 2025 EPS Forecast to -3.69 USD

12:23

Berenberg Analyst Maintains Buy Rating on BioNTech SE

06:51

Nov13

Pfizer Plans to Sell Shares in Biontech, Biontech Stock Dips

16:20

BioNTech Announces Unchanged Partnership with Pfizer

13:14

Schedules & Filings

Schedules

Filings

Nov3

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 1.781 B, Net Income -33.66 M, EPS -0.1407

BioNTech SE (BNTX.US) Q3 2025 Earnings Conference Call

Aug4

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 305.28 M, Net Income -452.53 M, EPS -1.8728

BioNTech SE (BNTX.US) Q2 2025 Earnings Conference Call

May5

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 197.88 M, Net Income -450.1 M, EPS -1.8726

BioNTech SE (BNTX.US) Q1 2025 Earnings Conference Call

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change